Incyte Statistics
Total Valuation
Incyte has a market cap or net worth of $11.78 billion. The enterprise value is $9.41 billion.
Market Cap | 11.78B |
Enterprise Value | 9.41B |
Important Dates
The last earnings date was Tuesday, April 29, 2025, before market open.
Earnings Date | Apr 29, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
Incyte has 193.57 million shares outstanding. The number of shares has decreased by -10.19% in one year.
Current Share Class | 193.57M |
Shares Outstanding | 193.57M |
Shares Change (YoY) | -10.19% |
Shares Change (QoQ) | +0.39% |
Owned by Insiders (%) | 0.80% |
Owned by Institutions (%) | 81.92% |
Float | 161.08M |
Valuation Ratios
The trailing PE ratio is 553.77 and the forward PE ratio is 10.30. Incyte's PEG ratio is 0.09.
PE Ratio | 553.77 |
Forward PE | 10.30 |
PS Ratio | 2.75 |
Forward PS | 2.42 |
PB Ratio | 3.22 |
P/TBV Ratio | 3.46 |
P/FCF Ratio | 38.91 |
P/OCF Ratio | 30.79 |
PEG Ratio | 0.09 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 31.04, with an EV/FCF ratio of 31.10.
EV / Earnings | 442.56 |
EV / Sales | 2.13 |
EV / EBITDA | 31.04 |
EV / EBIT | 44.89 |
EV / FCF | 31.10 |
Financial Position
The company has a current ratio of 2.04, with a Debt / Equity ratio of 0.01.
Current Ratio | 2.04 |
Quick Ratio | 1.88 |
Debt / Equity | 0.01 |
Debt / EBITDA | 0.14 |
Debt / FCF | 0.14 |
Interest Coverage | 83.55 |
Financial Efficiency
Return on equity (ROE) is 0.47% and return on invested capital (ROIC) is 2.87%.
Return on Equity (ROE) | 0.47% |
Return on Assets (ROA) | 2.03% |
Return on Invested Capital (ROIC) | 2.87% |
Return on Capital Employed (ROCE) | 5.21% |
Revenue Per Employee | $1.69M |
Profits Per Employee | $8,128 |
Employee Count | 2,617 |
Asset Turnover | 0.69 |
Inventory Turnover | 43.54 |
Taxes
In the past 12 months, Incyte has paid $293.39 million in taxes.
Income Tax | 293.39M |
Effective Tax Rate | 93.24% |
Stock Price Statistics
The stock price has increased by +14.68% in the last 52 weeks. The beta is 0.68, so Incyte's price volatility has been lower than the market average.
Beta (5Y) | 0.68 |
52-Week Price Change | +14.68% |
50-Day Moving Average | 61.85 |
200-Day Moving Average | 67.44 |
Relative Strength Index (RSI) | 51.44 |
Average Volume (20 Days) | 1,878,798 |
Short Selling Information
The latest short interest is 6.41 million, so 3.31% of the outstanding shares have been sold short.
Short Interest | 6.41M |
Short Previous Month | 7.42M |
Short % of Shares Out | 3.31% |
Short % of Float | 3.98% |
Short Ratio (days to cover) | 2.94 |
Income Statement
In the last 12 months, Incyte had revenue of $4.41 billion and earned $21.27 million in profits. Earnings per share was $0.10.
Revenue | 4.41B |
Gross Profit | 1.64B |
Operating Income | 209.72M |
Pretax Income | 351.14M |
Net Income | 21.27M |
EBITDA | 303.28M |
EBIT | 209.72M |
Earnings Per Share (EPS) | $0.10 |
Balance Sheet
The company has $2.41 billion in cash and $43.12 million in debt, giving a net cash position of $2.37 billion or $12.22 per share.
Cash & Cash Equivalents | 2.41B |
Total Debt | 43.12M |
Net Cash | 2.37B |
Net Cash Per Share | $12.22 |
Equity (Book Value) | 3.67B |
Book Value Per Share | 18.93 |
Working Capital | 1.79B |
Cash Flow
In the last 12 months, operating cash flow was $382.59 million and capital expenditures -$79.88 million, giving a free cash flow of $302.71 million.
Operating Cash Flow | 382.59M |
Capital Expenditures | -79.88M |
Free Cash Flow | 302.71M |
FCF Per Share | $1.56 |
Margins
Gross margin is 37.05%, with operating and profit margins of 4.75% and 0.48%.
Gross Margin | 37.05% |
Operating Margin | 4.75% |
Pretax Margin | 7.13% |
Profit Margin | 0.48% |
EBITDA Margin | 6.87% |
EBIT Margin | 4.75% |
FCF Margin | 6.86% |
Dividends & Yields
Incyte does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | 10.19% |
Shareholder Yield | 10.19% |
Earnings Yield | 0.18% |
FCF Yield | 2.57% |
Analyst Forecast
The average price target for Incyte is $73.06, which is 20.07% higher than the current price. The consensus rating is "Hold".
Price Target | $73.06 |
Price Target Difference | 20.07% |
Analyst Consensus | Hold |
Analyst Count | 20 |
Revenue Growth Forecast (5Y) | -0.42% |
EPS Growth Forecast (5Y) | 94.55% |
Stock Splits
The last stock split was on September 1, 2000. It was a forward split with a ratio of 2:1.
Last Split Date | Sep 1, 2000 |
Split Type | Forward |
Split Ratio | 2:1 |
Scores
Incyte has an Altman Z-Score of 4.85 and a Piotroski F-Score of 5.
Altman Z-Score | 4.85 |
Piotroski F-Score | 5 |